1
TXG
10X Genomics, Inc.
64.42
+0.55+0.86%Opening14:16 08/21 EDT
OPEN/PREV CLOSE64.39/63.87
TODAY RANGE61.75-65.11
VOL1.76M
MARKET CAP8.39B
52 WEEK RANGE11.16-65.11
AVG VOL (3M)3.26M
% TURNOVER1.35%
TURNOVER--
P/E (TTM)-109.2420
% RANGE5.26%
EPS(TTM)-0.5897
P/E(FORWARD)-85.9300
P/B10.17
BVPS6.34
DIVIDEND--
P/S12.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.62B
SHARES OUTSTANDING130.29M
NEXT EARNINGS11/04-11/09
FREE FLOAT118.32M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance
Seeking Alpha·4d ago
Cathie Wood's Ark adds $30M Cloudflare, $27M Nvidia; cuts $60M Deere
TipRanks·4d ago
10x Genomics price target raised to $65 from $50 at Stephens
TipRanks·08/14 02:10
Insider Shake-Up at 10x Genomics Signals a Major Move
Simply Wall St·08/13 14:24
Why 10x Genomics (TXG) Is Up 21.7% After Raising 2026 Outlook Despite Q2 Revenue Drop
Dow Jones·08/12 16:31
10x Genomics Is Maintained at Overweight by Stephens & Co.
Dow Jones·08/12 16:31
10x Genomics Price Target Raised to $65.00/Share From $50.00 by Stephens & Co.
Benzinga·08/12 16:21
Stephens & Co. Maintains Overweight on 10x Genomics, Raises Price Target to $65
TipRanks·08/12 13:36
10x Genomics (TXG) Gets a Buy from Stephens
Simply Wall St·08/12 11:12
US$49.54 - That's What Analysts Think 10x Genomics, Inc. (NASDAQ:TXG) Is Worth After These Results
Dow Jones·08/10 18:47
10x Genomics Is Maintained at Neutral by Piper Sandler
Benzinga·08/10 18:37
Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $47
Same Industry